(Q36755157)

16 August 2017

Oral labetalol in the management of stable angina pectoris in normotensive patients (English)

1 reference

16 August 2017

1 reference

Upward JW

1

1 reference

PMCID

481721

16 August 2017

Akhras F

series ordinal

2

1 reference

PMCID

481721

16 August 2017

Jackson G

series ordinal

3

1 reference

16 August 2017

1 January 1985

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

53

1 reference

16 August 2017

1

1 reference

16 August 2017

53-57

1 reference

Early exercise testing and coronary angiography after uncomplicated myocardial infarction.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Exacerbation of angina pectoris by prazosin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Pharmacological basis for antihypertensive effects of intravenous labetalol

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481721

Effects of propranolol on exercise tolerance in angina pectoris

5 September 2018

1 reference

12 December 2020

Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris

1 reference

12 December 2020

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience

1 reference

12 December 2020

Labetalol infusion for the treatment of hypertension in acute myocardial infarction

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.53.1.53

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

PMCID

481721